Embecta Corp Price Book Value Ratio Over Time

EMBC Stock  USD 18.68  0.13  0.69%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Embecta Corp Performance and Embecta Corp Correlation.
For information on how to trade Embecta Stock refer to our How to Trade Embecta Stock guide.
  
The current year's Price Book Value Ratio is expected to grow to -1.15.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Embecta Corp. If investors know Embecta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Embecta Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.04)
Earnings Share
1.34
Revenue Per Share
19.438
Quarterly Revenue Growth
(0.05)
Return On Assets
0.0964
The market value of Embecta Corp is measured differently than its book value, which is the value of Embecta that is recorded on the company's balance sheet. Investors also form their own opinion of Embecta Corp's value that differs from its market value or its book value, called intrinsic value, which is Embecta Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Embecta Corp's market value can be influenced by many factors that don't directly affect Embecta Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Embecta Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Embecta Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Embecta Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Price Book Value Ratio Analysis

Compare Embecta Corp and related stocks such as Baxter International, West Pharmaceutical, and ResMed Inc Price Book Value Ratio Over Time
Select Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueCapex To Depreciation
Pb RatioEv To Sales
Free Cash Flow Per ShareRoic
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityRoe
Tangible Asset ValueEv To Operating Cash Flow
Pe RatioReturn On Tangible Assets
Ev To Free Cash FlowIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Dividend YieldEarnings Yield
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
2010201120122013201420152016201720182019202020212022202320242025
BAX0.60092.32272.87572.4242.65792.35042.92033.84694.50965.44.70044.74734.40412.32832.12.1
WST1.70711.95342.55433.76723.94474.23465.56425.69715.18837.071211.289614.94156.52179.08118.178.58
RMD11.12082.83163.96684.07384.98845.23215.61547.1828.547211.098412.41399.1117.76495.65055.094.77
COO0.66730.52440.6530.76620.69250.79060.92480.95863.96184.09562.99061.87862.04382.57582.322.43
ICUI20.21411.92652.21722.01362.46253.08233.60883.53573.92532.80282.98513.11441.79851.13161.31.24
MMSI11.66671.46451.53641.6531.71781.75632.36223.11743.12731.813.21013.3643.50553.63964.193.6
ANGO2.94610.58390.7190.93611.05470.85331.0681.4371.14560.86442.04951.80390.98731.23331.111.17
ATR2.34772.6922.2963.02863.93013.95583.92944.10674.12884.67614.76564.08373.5023.51633.162.26
TFX2.00061.25331.63792.01622.4852.71883.26354.60724.64955.83745.73454.0922.91082.63782.372.05
ALC1.21.21.21.21.21.21.23261.23171.25291.43071.71422.21691.71191.8681.681.23
HAE2.84322.82532.82532.82532.82532.82532.82535.13735.13735.13735.13735.13735.13734.50835.12952.79
NVST0.86590.86590.86590.86590.86590.86590.86590.86590.89591.14031.44691.79011.30380.96210.870.96
AKYA(24.6099)(24.6099)(24.6099)(24.6099)(24.6099)(24.6099)(24.6099)(24.6099)(24.6099)(24.6099)39.96614.72156.16654.03273.634.85
ATRC14.361711.14078.93695.25663.97193.37263.67243.66544.18264.94065.68656.47734.44433.54543.193.76

Embecta Corp and related stocks such as Baxter International, West Pharmaceutical, and ResMed Inc Price Book Value Ratio description

My Equities

My Current Equities and Potential Positions

Embecta Corp
EMBC
ClassificationMedical Equipment
LocationDelaware; U.S.A
ExchangeNASDAQ Exchange
USD 18.68
When determining whether Embecta Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Embecta Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Embecta Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Embecta Corp Stock:
Check out Embecta Corp Performance and Embecta Corp Correlation.
For information on how to trade Embecta Stock refer to our How to Trade Embecta Stock guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Embecta Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Embecta Corp technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Embecta Corp trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...